L553-1733 Screening compound: 3-[4-(3,5-dimethylpiperidin-1-yl)-3-methyl-[1,2]oxazolo[5,4-d]pyrimidin-6-yl]-N-[(pyridin-2-yl)methyl]propanamide

L553-1733 Screening compound: 3-[4-(3,5-dimethylpiperidin-1-yl)-3-methyl-[1,2]oxazolo[5,4-d]pyrimidin-6-yl]-N-[(pyridin-2-yl)methyl]propanamide
L553-1733 Screening compound: 3-[4-(3,5-dimethylpiperidin-1-yl)-3-methyl-[1,2]oxazolo[5,4-d]pyrimidin-6-yl]-N-[(pyridin-2-yl)methyl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L553-1733
3-[4-(3,5-dimethylpiperidin-1-yl)-3-methyl-[1,2]oxazolo[5,4-d]pyrimidin-6-yl]-N-[(pyridin-2-yl)methyl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L553-1733

Molecular Formula

C22H28N6O2 (C22 H28 N6 O2)

Compound Name

3-[4-(3,5-dimethylpiperidin-1-yl)-3-methyl-[1,2]oxazolo[5,4-d]pyrimidin-6-yl]-N-[(pyridin-2-yl)methyl]propanamide

IUPAC name

3-[4-(35-dimethylpiperidin-1-yl)-3-methyl-[12]oxazolo[54-d]pyrimidin-6-yl]-N-[(pyridin-2-yl)methyl]propanamide

SMILES

CC(CC(C)C1)CN1c1c(c(C)no2)c2nc(CCC(NCc2ncccc2)=O)n1

InChI

InChI=1S/C22H28N6O2/c1-14-10-15(2)13-28(12-14)21-20-16(3)27-30-22(20)26-18(25-21)7-8-19(29)24-11-17-6-4-5-9-23-17/h4-6,9,14-15H,7-8,10-13H2,1-3H3,(H,24,29)

InChI Key

YWQUOPOXRMIOED-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27461475

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

408.5

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.981

Distribution Coefficient, logD

2.979

Water Solubility, LogSw

-3.42

Polar Surface Area

78.974

Acid Dissociation Constant (pKa)

12.67

Base Dissociation Constant (pKb)

5.03

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

50.00

L553-1733 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
  • Proteases
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L553-1733 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L553-1733?
Check Price and Availability of L553-1733, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L553-1733 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L553-1733
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L553-1733
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L553-1733 available by request